High Court Passes On Lupron Labeling Suit

Law360, New York (December 9, 2013, 2:27 PM EST) -- The U.S. Supreme Court refused on Monday to hear a Nevada woman's claims that her suit against TAP Pharmaceutical Products Inc. and Abbott Laboratories over allegedly debilitating Lupron side effects was doomed by a federal judge's bias and exclusion of relevant evidence.

The high court's denial of writ of certiorari means the Ninth Circuit's May affirmation of a jury verdict against petitioner Karin Klein will stand. Klein had argued that while the drug's side effects left her disabled, at trial U.S. District Judge Roger L. Hunt refused to allow the jury to consider old Lupron labels showing the companies had previously...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!